Deadline Monday for pharmacies' annual inventory of controlled dangerous substances - The Oklahoman
Deadline Monday for pharmacies' annual inventory of controlled dangerous substances - The Oklahoman — DEA update affecting Pharmacy & Controlled Substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmacy & Controlled Substances (independent pharmacies, compounding pharmacies, long-term-care pharmacies) should confirm how it applies to their specific situation before acting. There is a time constraint attached: as soon as possible. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Deadline Monday for pharmacies' annual inventory of controlled dangerous substances - The Oklahoman
Who it affects
Pharmacy & Controlled Substances (independent pharmacies, compounding pharmacies, long-term-care pharmacies)
What you must do
Check the effective date and complete any required filing, registration, or update before it takes effect.
Deadline
as soon as possible
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Press Releases | State of California - Department of Justice - Office of the Attorney General
- PSM signs letter of support for changes to Mississippi’s compounding pharmacy guidelines - safemedicines.org
- Iowa sees past Novo’s spin - Alliance for Pharmacy Compounding
- State updates: February 27 - Alliance for Pharmacy Compounding
- Maryland: What we’ve got here is a failure to communicate - Alliance for Pharmacy Compounding